Moderna plans to price vaccine under $40 per dose

U.S. & World

(CNN) – One of the companies working on a coronavirus vaccine said Wednesday that it’s on track to finish enrollment for a Phase Three study before October.

Moderna also said it plans to make the vaccine affordable — below 40 dollars per dose for most customers.

This comes as all drug companies are being closely watched to see what they plan to charge for COVID-19 treatments.

In June, Biotech Gilead Sciences revealed that its remdesivir drug would cost more than 500 dollars a vial for people with private health insurance.

Moderna is just one of several U.S. drug companies racing to come up with a successful vaccine. Novavax and Pfizer have also had promising vaccine results so far.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Video on

Don't Miss

Interactive Radar

More As Seen on 2 NEWS